MedPath

Desloratadine

Generic Name
Desloratadine
Brand Names
Aerius, Clarinex, Clarinex-D, Neoclarityn, Desloratadine ratiopharm, Desloratadine Teva, Desloratadine Actavis, Dasselta, Azomyr
Drug Type
Small Molecule
Chemical Formula
C19H19ClN2
CAS Number
100643-71-8
Unique Ingredient Identifier
FVF865388R
Background

Desloratadine is a second generation, tricyclic antihistamine that which has a selective and peripheral H1-antagonist action. It is the active descarboethoxy metabolite of loratidine (a second generation histamine). Desloratidine has a long-lasting effect and does not cause drowsiness because it does not readily enter the central nervous system.

Indication

For the relief of symptoms of seasonal allergic rhinitis, perennial (non-seasonal) allergic rhinitis. Desloratidine is also used for the sympomatic treatment of pruritus and urticaria (hives) associated with chronic idiopathic urticaria.

Associated Conditions
Allergic Rhinitis (AR), Asthma, Chronic Idiopathic Urticaria, Common Cold, Nasal Congestion, Perennial Allergic Rhinitis (PAR), Seasonal Allergic Rhinitis, Nasal symptoms, Non-nasal symptoms
Associated Therapies
Antihistamine

Anti-inflammatory H1 Antihistamines Allergic Rhinitis

Phase 4
Completed
Conditions
Allergic Rhinitis
Interventions
First Posted Date
2015-07-24
Last Posted Date
2015-07-24
Lead Sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Target Recruit Count
115
Registration Number
NCT02507635

Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)

Phase 3
Completed
Conditions
Seasonal Allergic Rhinitis
Interventions
First Posted Date
2014-12-19
Last Posted Date
2024-05-17
Lead Sponsor
Organon and Co
Target Recruit Count
449
Registration Number
NCT02320396

Anti-histamines and Methacholine Challenges.

Phase 4
Completed
Conditions
Asthma
Interventions
First Posted Date
2013-11-15
Last Posted Date
2015-04-08
Lead Sponsor
Don Cockcroft
Target Recruit Count
12
Registration Number
NCT01985789
Locations
🇨🇦

University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria

First Posted Date
2013-09-12
Last Posted Date
2014-02-19
Lead Sponsor
Grupo de Alergología Clínica y Experimental
Target Recruit Count
150
Registration Number
NCT01940393
Locations
🇨🇴

Medellin, Medellin, Antioquia, Colombia

A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)

Phase 3
Completed
Conditions
Perennial Allergic Rhinitis
Interventions
First Posted Date
2013-08-07
Last Posted Date
2024-06-18
Lead Sponsor
Organon and Co
Target Recruit Count
608
Registration Number
NCT01918033

Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)

Phase 3
Completed
Conditions
Eczema
Dermatitis
Dermal Pruritus
Interventions
First Posted Date
2013-08-06
Last Posted Date
2024-06-18
Lead Sponsor
Organon and Co
Target Recruit Count
94
Registration Number
NCT01916980

An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)

Phase 3
Completed
Conditions
Urticaria
Interventions
Drug: Placebo
First Posted Date
2013-08-06
Last Posted Date
2024-06-18
Lead Sponsor
Organon and Co
Target Recruit Count
239
Registration Number
NCT01916967

Comparison of Desloratadine Associated With Prednisolone (Tablet)Versus Dexchlorpheniramine Associated With Betamethasone (Tablet) for Adult Persistent Allergic Rhinitis Treatment

First Posted Date
2012-11-02
Last Posted Date
2013-09-25
Lead Sponsor
EMS
Target Recruit Count
234
Registration Number
NCT01720485
Locations
🇧🇷

IMA - Instituto de Pesquisa Clínica e Medicina Avançada, São Paulo, Brazil

Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment

Phase 3
Terminated
Conditions
Cutaneous Hypersensitivity
Interventions
First Posted Date
2012-02-08
Last Posted Date
2017-02-16
Lead Sponsor
EMS
Target Recruit Count
17
Registration Number
NCT01529242
Locations
🇧🇷

Allergisa, Campinas, São Paulo, Brazil

🇧🇷

Hospital Nipo Brasileiro, São Paulo, Brazil

🇧🇷

Alergoalpha, São Paulo, SP, Brazil

Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Persistent Allergic Rhinitis Treatment

Phase 3
Completed
Conditions
Allergic Rhinitis
Interventions
First Posted Date
2012-02-08
Last Posted Date
2015-01-15
Lead Sponsor
EMS
Target Recruit Count
210
Registration Number
NCT01529229
© Copyright 2025. All Rights Reserved by MedPath